Camras Vision

We are developing a therapy that can stop the loss of vision caused by glaucoma and provide the first-ever personalized care for patients.

Durham, NC, USA
Medical Devices and Equipment

Company Overview

Camras Vision is an ophthalmic medical device company developing a patented new technology for the 67 million glaucoma sufferers. Ophthalmologists are faced with limited surgical treatments due to their instability and unpredictability in controlling glaucoma. As a result, 1 out of 10 patients still lose their vision even when properly treated. Camras Vision wishes to address these problems with their device, the Camras Shunt.

Management Team

  • Default_avatar

    Roberto Alfaro

    Roberto Alfaro’s previous experience as a Manager for Deloitte has given him detailed knowledge in developing and improving operational processes, managing a multi-billion dollar project, selling clients new services, and managing projects domestically and internationally. While in graduate school at Duke University, he has consulted to start-ups in the biomedical and tech industries.
  • Default_avatar

    Lucinda Camras

    Chief Scientific Officer
    Lucinda Camras has been working in aqueous humor dynamics and biomedical engineering for almost a decade. She has five patents issued or pending in the ophthalmology field. She also served as the Dir. of Scientific Research at ACE Vision Group, a start-up ophthalmic company going through clinical trials overseas. Lucinda has presented at numerous conferences, published in reputable ophthalmic journals, and received various awards.

Company Info

Product In Development
2 Employees
Founded: October 2010